# Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects

> **NCT02818699** · NA · COMPLETED · sponsor: **Tufts University** · enrollment: 65 (actual)

## Conditions studied

- Overweight
- Obese

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** EMIQ

## Key facts

- **NCT ID:** NCT02818699
- **Lead sponsor:** Tufts University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-01
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-09-14
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02818699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02818699, "Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02818699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*